Knowing if you have an inherited (also called genetic) BRCA1 or BRCA2 mutation is a vital part of treatment planning for people diagnosed with breast cancer because treatment options differ depending on your BRCA1/2 status.
Below you will find links to articles discussing why doctors do not offer BRCA1/2 testing to African American women diagnosed with breast cancer as often as white women diagnosed with breast cancer. You can also learn how common BRCA1/2 and other mutations are in Black women from the Bahamas and other countries. Finally, keep reading to learn about Black & BRCA — a collaboration between patient advocates and the Basser Center for BRCA at Penn University.
- BU School of Medicine: African American and White Women Share Genes that Increase Breast Cancer Risk
- The University of Miami, Miller School of Medicine: Significant New Findings of Breast and Ovarian Cancer in Patients from the Caribbean
- Penn Medicine: Black & BRCA
Tags:Patient AdvocacyGenetics & GenomicsResources and Support